Novartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range

marketwatch.com/story/novartis-to-buy-u-s-biotech-in-latest-deal-targeting-firms-in-1-billion-to-3-billion-range-4184f9f4

Novartis on Tuesday said it was buying a U.S. biotech working on a cardiovascular drug, continuing what’s been a flurry of acquisitions at a similar price point.

This story appeared on marketwatch.com, 2025-09-09 09:39:00.
The Entire Business World on a Single Page. Free to Use →